Beleave Provides Business Update

TORONTO, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has received notification from Health Canada that, upon the Company's confirmation that the Company's production, testing, manufacturing, packaging, storing, labelling, shipping and record-keeping of product intended for sale is in … [Read more...]

Resverlogix Announces Filing of Quarterly Financial Statements and Management’s Discussion & Analysis

CALGARY, Alberta, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) announced today that it has filed its unaudited interim Consolidated Financial Statements and Management’s Discussion & Analysis for the quarter ended October 31, 2017 with Canadian securities regulatory authorities. Copies of these documents may be obtained … [Read more...]

Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae

PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae New York, USA, Melbourne, Australia and Leuven, Belgium, December 15, 2017, 00:20h CET - Mesoblast Limited (ASX: MSB; Nasdaq: MESO) and TiGenix NV (Euronext Brussels … [Read more...]

INC Research/inVentiv Health to Present at Upcoming J.P. Morgan Healthcare Conference

RALEIGH, N.C., Dec. 14, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco. Mr. Macdonald’s presentation is scheduled for Tuesday, … [Read more...]

Galena Will Adjourn Special Meeting until Friday, December 29, 2017, Urges Stockholders to Vote

SAN RAMON, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), (“Galena”) announced today that its special meeting of stockholders (“Special Meeting”), scheduled for December 15, 2017, will be convened and adjourned, without any business being conducted, in order to allow sufficient time for stockholders to vote based upon a change in information … [Read more...]